Indian stock markets opened sharply higher on Monday, with Sensex gaining over 900 points to 76,294 and Nifty 50 rising 242 points to 23,961 as of 10:26 am. The sharp gains added nearly ₹5 lakh crore to the total market capitalisation, pulling it up to around ₹468 lakh crore. According to Moneycontrol, the optimism was driven by rising hopes for the US-Iran peace deal and falling oil prices, with crude dipping by $5 to below $100 on expectations that the US and Iran are close to a deal. India VIX, which measures volatility in the market, tumbled over 4% to 17.15 in the morning session.
The rally was broad-based with Nifty Midcap 100 and Nifty Smallcap 100 indices gaining up to 1%. As reported by Moneycontrol, Mahindra & Mahindra (M&M), Bajaj Finance, HDFC Bank, L&T, Bajaj Finserv, Eternal, Maruti Suzuki and UltraTech Cement shares gained around 2% each to lead gains on Sensex. However, TCS, NTPC, Sun Pharma and Infosys shares were trading in the red with marginal losses. Sectorally, Nifty Auto rallied over 2% to lead gains, while Nifty IT slipped into the red with marginal losses. Around 2,116 stocks advanced on NSE, while 456 declined and 104 remained unchanged.
Eicher Motors shares gained 5 percent following the automaker's strong Q4 performance. According to reports from Moneycontrol, the company reported an 11.6% increase in Q4 consolidated net profit at ₹1,520 crore versus ₹1,362.2 crore in the year-ago period. Revenue from operations surged 16% YoY to ₹6,080.1 crore from ₹5,241.1 crore, demonstrating robust operational performance.
Hindalco Industries shares declined more than 2 percent after the company posted disappointing Q4 results. As reported by Moneycontrol, the company experienced a 50.9% YoY fall in consolidated net profit to ₹2,597 crore for the fourth quarter, compared to ₹5,284 crore a year earlier. Despite the sharp decline in profitability, revenue rose 20.4% YoY to ₹78,133 crore from ₹64,890 crore, indicating mixed operational performance.
NTPC shares traded flat despite the company reporting positive Q4 results. According to Moneycontrol, the company achieved a 34.4% year-on-year increase in consolidated net profit for Q4 at ₹10,615 crore, compared to ₹7,897.1 crore in the same period last year. However, revenue from operations declined marginally by 0.3% YoY to ₹49,687.8 crore from ₹49,833.7 crore, showing mixed operational trends.
Gujarat Themis Biosyn shares rose 6.5% after the company entered into a definitive agreement to acquire a 100% equity stake in MicroBiopharm Japan Co from funds managed by Japan-based private equity firm T Capital Partners Co. The acquisition, valued at ₹1,300 crore, is expected to be completed in Q2 FY2027. Meanwhile, Aurobindo Pharma shares fell 1% after the US FDA classified the Telangana-based facility of subsidiary Eugia Pharma Specialities as Official Action Indicated following an inspection.
RBL Bank shares added nearly 2% after Emirates NBD Bank announced an open offer to acquire up to 41.55 crore shares representing 26% of the expanded voting share capital at ₹282.38 per share. The total size of the open offer is estimated at ₹11,735.3 crore, as reported by Moneycontrol. Market participants noted that news flow remains a key driver in the current environment, with investors closely tracking corporate announcements and sector-specific triggers.
